TABLE 2.
Baseline demographic in patients with and without GER+.
| Overall (n = 129) | GER− (n = 60) | GER+ (n = 69) | p-value | |
|---|---|---|---|---|
|
| ||||
| Age (years) | 54.1 (17.5) | 53.3 (18.3) | 54.8 (16.8) | 0.63 |
| Sex (female) | 84/128 (66%) | 42 (70%) | 42/68 (62%) | 0.33 |
| BMI (kg/m2) | 27.6 (6.8) | 25.5 (5.9) | 29.4 (7.0) | <0.01 |
| Race (n = 137) | ||||
| Caucasian | 84 (66%) | 41 (68%) | 43 (62%) | 0.15 |
| African American | 5 (4%) | 4 (7%) | 1 (1%) | |
| Asian | 8 (6%) | 4 (7%) | 4 (6%) | |
| Hispanic | 17 (13%) | 8 (13%) | 9 (13%) | |
| Native American | 0 (0%) | 0 (0%) | 0 (0%) | |
| Unknown/other | 15 (12%) | 3 (5%) | 12 (17%) | |
| Total LCAT | 33.0 (13.1) | 32.9 (13.8) | 33.1 (12.6) | 0.91 |
| LCAT symptom-specific anxiety | 17.9 (9.2) | 18.0 (9.6) | 17.8 (9.1) | 0.87 |
| LCAT hypervigilance | 15.1 (4.9) | 14.8 (5.1) | 15.3 (4.8) | 0.56 |
| Elevated LCAT ≥33 | 73 (57%) | 35 (58%) | 38 (55%) | 0.71 |
| PROMIS anxiety, n = 127 | 17.2 (7.4) | 17.5 (7.6) | 16.9 (7.3) | 0.61 |
| PROMIS anxiety ≥20 (moderate/severe anxiety) | 49/127 (39%) | 26 (43%) | 23/67 (34%) | 0.30 |
| PROMIS depression, n = 126 | 14.8 (7.6) | 15.5 (7.6) | 14.2 (7.6) | 0.33 |
| PROMIS depression >22 (moderate/severe depression) | 24/126 (19%) | 13/60 (22%) | 11/66 (17%) | 0.48 |
| ICQ helplessness | 11.2 (4.3) | 11.3 (4.0) | 11.1 (4.6) | 0.75 |
| ICQ acceptance | 15.2 (3.9) | 14.8 (4.0) | 15.5 (3.9) | 0.32 |
| ICQ perceived benefits | 12.6 (4.7) | 12.7 (4.8) | 12.5 (4.7) | 0.85 |
| NEQOL, n = 128 | 31.7 (14.5) | 31.2 (14.3) | 32.2 (14.8) | 0.71 |
| VHI, n = 125 | 22.4 (25.5) | 21.5 (23.1) | 23.1 (27.5) | 0.73 |
| RSI, n = 126 | 21.8 (10.4) | 20.9 (10.5) | 22.6 (10.2) | 0.34 |
| GerdQ | 8.9 (2.8) | 8.2 (2.7) | 9.6 (2.7) | <0.01 |
| AET prolonged wireless pH monitoring off PPI, n = 77 | 8.2 (7.9) | 2.5 (2.0) n = 30 | 11.9 (8.1) n=47 | <0.01 |
| AET PHI off PPI, n=42 | 3.3 (4.4) | 1.7 (1.7) n = 31 | 8.0 (6.3) n = 11 | <0.01 |